Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Efficacy of Ciclesonide vs Fluticasone Added to Tiotropium and Salmeterol in COPD
NCT00535366Phase 2Completed
- Sponsor
- Boehringer Ingelheim
- Start
- Oct 2007
- Primary completion
- Sep 2008
- Modality
- Orthosteric Ligands
- Countries
- 4
01
Overview
A Phase 2 trial of ciclesonide in chronic obstructive pulmonary disease (COPD), sponsored by Boehringer Ingelheim. Started Oct 2007; status: completed.
02
Drugs
ciclesonide
03
Conditions
chronic obstructive pulmonary disease (COPD)
Beyond the preview
Go deeper on NCT00535366.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00535366.